Portfolio (Quarterly)
Guide ↗
Trails Edge Capital Partners, LP
· CIK 0002077247| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | XFOR | X4 PHARMACEUTICALS INC | Healthcare | 2,571,478.0 | $12.0M | 1.91% | — | — | $4.67 | -13.5% |
| 22 | — | OPUS GENETICS INC | — | 2,743,658.0 | $11.3M | 1.79% | +2.2M | +448.7% | $4.11 | — |
| 23 | SLGL | SOL-GEL TECHNOLOGIES LTD | Healthcare | 139,445.0 | $10.3M | 1.64% | +54K | +63.1% | $74.14 | +4.8% |
| 24 | AURA | AURA BIOSCIENCES INC | Healthcare | 1,443,333.0 | $10.2M | 1.63% | NEW | — | $7.10 | +9.9% |
| 25 | IPSC | CENTURY THERAPEUTICS INC | Healthcare | 4,134,969.0 | $10.1M | 1.61% | +1.7M | +68.8% | $2.45 | -15.5% |
| 26 | IVA | INVENTIVA SA | Healthcare | 2,657,997.0 | $10.0M | 1.59% | — | — | $3.78 | +23.8% |
| 27 | CAMP | CAMP4 THERAPEUTICS CORP | Healthcare | 1,932,937.0 | $8.4M | 1.34% | — | — | $4.37 | +2.5% |
| 28 | ALT | ALTIMMUNE INC | Healthcare | 2,660,000.0 | $8.1M | 1.28% | NEW | — | $3.04 | +2.3% |
| 29 | NERV | MINERVA NEUROSCIENCES INC | Healthcare | 1,419,000.0 | $7.9M | 1.25% | — | — | $5.55 | -12.8% |
| 30 | — | PROMIS NEUROSCIENCES INC | — | 557,103.0 | $7.3M | 1.16% | — | — | $13.16 | — |
| 31 | — | ONKURE THERAPEUTICS INC | — | 1,438,456.0 | $6.6M | 1.04% | NEW | — | $4.56 | — |
| 32 | — | FORTE BIOSCIENCES INC | — | 273,181.0 | $5.8M | 0.92% | NEW | — | $21.25 | — |
| 33 | — | RESEARCH ALLIANCE CORP III | — | 500,000.0 | $5.3M | 0.85% | NEW | — | $10.70 | — |
| 34 | — | VTV THERAPEUTICS INC | — | 85,192.0 | $3.2M | 0.51% | -54K | -39.0% | $37.65 | — |
| 35 | IMA | IMAGENEBIO INC | Healthcare | 282,004.0 | $1.7M | 0.26% | NEW | — | $5.90 | -6.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%